DAPHNE GALLUCCI: Open Payments
NPI 1285349712 · JOHNSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,222 in 138 payments from 15 companies in 2025. Trend: 2023 $2,151 · 2024 $3,722 · 2025 $3,222
Food & beverage: $3,222
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 49 | $1,432 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 15 | $464 |
| GENZYME CORPORATION | 11 | $233 |
| Actelion Pharmaceuticals US, Inc. | 9 | $229 |
| Amgen Inc. | 8 | $157 |
| GlaxoSmithKline, LLC. | 18 | $146 |
| Regeneron Healthcare Solutions, Inc. | 5 | $112 |
| Philips North America LLC | 5 | $101 |
| Viatris Specialty LLC | 5 | $98 |
| Grifols USA, LLC | 4 | $89 |
Products named: TEZSPIRE, OFEV, AIRSUPRA, DUPIXENT, FASENRA, OPSYNVI, Vest Therapy Und, YUPELRI.
Industry payments across PA — which companies pay providers there.
